English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/171651
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Release of antidiabetic peptides during simulated gastrointestinal digestion of quinoa (Chenopodium quinoa Willd) proteins

AuthorsVilcacundo, Rubén; Martínez Villaluenga, Cristina ; Hernández-Ledesma, Blanca
KeywordsAnti-diabetic peptides
Gastrointestinal digestion
Quinoa
Issue Date2018
Citation3er Congreso Internacional de Alimentos Funcionales y Nutracéuticos (2018)
Abstract[Introduction]: The amino acids, peptides and proteins derived from foods stand out among the most studied natural compounds in virtue of their modulating properties of glucose levels in diabetic individuals. Quinoa has been recognized as one of the >grains of the 21st century> due to its high nutritional and functional value. However, no data on its potential as source of peptides with the ability to control glycemia have been reported. [Methods]: Quinoa proteins were subjected to gastrointestinal digestion simulating physiological conditions. In vitro anti-diabetic activity was measured in gastric and gastroduodenal digests and peptidic fractions obtained from them, evaluating their ability to inhibit dipeptidyl peptidase IV (DPP-IV), α-amylase, and α-glucosidase. The most active digest was analyzed by HPLC-MS/MS to identify the peptides potentially responsible for the observed effects. [Results]: Pepsin partially hydrolyzed quinoa proteins that were completely degraded by the action of pancreatin. Gastroduodenal digests obtained after 60 and 120 min-incubation with pancreatin showed inhibition values for the three enzymes between 2.5 and 7 times higher than those shown by the gastric digest. The IC50 values determined in the 60 mingastroduodenal digest were 0.23 mg protein/mL (DPP-IV), 0.53 mg protein/mL (α-amylase), and 1.75 mg protein/mL (α-glucosidase). The fraction containing the smallest peptides was mainly responsible for the inhibitory effects shown by the gastroduodenal digests. Three novel in vitro antidiabetic peptides, which sequences were IQAEGGLT, DKDYPK, and GEHGSDGNV, were identified. [Conclusions]: This is the first report on the potential of gastrointestinal digestion to release anti-diabetic peptides from quinoa proteins. Three novel sequences derived from 11S seed storage globulin B with ability to inhibit enzymes involved in incretin degradation and digestion of dietary carbohydrates has been demonstrated. Thus, quinoa proteins are presented as promising ingredients of functional foods for the prevention and/or management of type-2 diabetes.
DescriptionResumen del póster presentado al 3er Congreso Internacional de Alimentos Funcionales y Nutracéuticos: "Diseño y desarrollo de alimentos funcionales y nutracéuticos para la nutrición humana", celebrado en Mazatlán, Sinaloa (México) del 20 al 22 de junio de 2018.
URIhttp://hdl.handle.net/10261/171651
Appears in Collections:(CIAL) Comunicaciones congresos
(ICTAN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.